img

Global Tardive Dyskinesia Treatment Medicine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tardive Dyskinesia Treatment Medicine Market Research Report 2024

Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary and repetitive movements, often affecting the face, tongue, lips, and other parts of the body. It is most commonly associated with the long-term use of certain medications, particularly antipsychotic medications used to treat conditions like schizophrenia and bipolar disorder. Tardive dyskinesia can be a challenging condition to manage, and treatment options aim to alleviate symptoms and improve the quality of life for affected individuals.
According to MRAResearch’s new survey, global Tardive Dyskinesia Treatment Medicine market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tardive Dyskinesia Treatment Medicine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Tardive Dyskinesia Treatment Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Teva Pharmaceutical
Neurocrine Biosciences
Sun Pharmaceutical
SteriMax
Adamas Pharmaceuticals (Supernus)
AbbVie
Segment by Type
Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
Botulinum Toxin
Others

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tardive Dyskinesia Treatment Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
1.2.3 Botulinum Toxin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia Treatment Medicine Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia Treatment Medicine Market Perspective (2018-2033)
2.2 Tardive Dyskinesia Treatment Medicine Growth Trends by Region
2.2.1 Global Tardive Dyskinesia Treatment Medicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tardive Dyskinesia Treatment Medicine Historic Market Size by Region (2018-2023)
2.2.3 Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Region (2024-2033)
2.3 Tardive Dyskinesia Treatment Medicine Market Dynamics
2.3.1 Tardive Dyskinesia Treatment Medicine Industry Trends
2.3.2 Tardive Dyskinesia Treatment Medicine Market Drivers
2.3.3 Tardive Dyskinesia Treatment Medicine Market Challenges
2.3.4 Tardive Dyskinesia Treatment Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia Treatment Medicine Players by Revenue
3.1.1 Global Top Tardive Dyskinesia Treatment Medicine Players by Revenue (2018-2023)
3.1.2 Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Tardive Dyskinesia Treatment Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tardive Dyskinesia Treatment Medicine Revenue
3.4 Global Tardive Dyskinesia Treatment Medicine Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia Treatment Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia Treatment Medicine Revenue in 2022
3.5 Tardive Dyskinesia Treatment Medicine Key Players Head office and Area Served
3.6 Key Players Tardive Dyskinesia Treatment Medicine Product Solution and Service
3.7 Date of Enter into Tardive Dyskinesia Treatment Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia Treatment Medicine Breakdown Data by Type
4.1 Global Tardive Dyskinesia Treatment Medicine Historic Market Size by Type (2018-2023)
4.2 Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Type (2024-2033)
5 Tardive Dyskinesia Treatment Medicine Breakdown Data by Application
5.1 Global Tardive Dyskinesia Treatment Medicine Historic Market Size by Application (2018-2023)
5.2 Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
6.2 North America Tardive Dyskinesia Treatment Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023)
6.4 North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
7.2 Europe Tardive Dyskinesia Treatment Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023)
7.4 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
8.2 Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
9.2 Latin America Tardive Dyskinesia Treatment Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023)
9.4 Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
10.2 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Detail
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Introduction
11.1.4 Teva Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.1.5 Teva Pharmaceutical Recent Development
11.2 Neurocrine Biosciences
11.2.1 Neurocrine Biosciences Company Detail
11.2.2 Neurocrine Biosciences Business Overview
11.2.3 Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Introduction
11.2.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.2.5 Neurocrine Biosciences Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Detail
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Introduction
11.3.4 Sun Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.3.5 Sun Pharmaceutical Recent Development
11.4 SteriMax
11.4.1 SteriMax Company Detail
11.4.2 SteriMax Business Overview
11.4.3 SteriMax Tardive Dyskinesia Treatment Medicine Introduction
11.4.4 SteriMax Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.4.5 SteriMax Recent Development
11.5 Adamas Pharmaceuticals (Supernus)
11.5.1 Adamas Pharmaceuticals (Supernus) Company Detail
11.5.2 Adamas Pharmaceuticals (Supernus) Business Overview
11.5.3 Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Introduction
11.5.4 Adamas Pharmaceuticals (Supernus) Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.5.5 Adamas Pharmaceuticals (Supernus) Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Tardive Dyskinesia Treatment Medicine Introduction
11.6.4 AbbVie Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.6.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
Table 3. Key Players of Botulinum Toxin
Table 4. Key Players of Others
Table 5. Global Tardive Dyskinesia Treatment Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Tardive Dyskinesia Treatment Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Tardive Dyskinesia Treatment Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Tardive Dyskinesia Treatment Medicine Market Share by Region (2018-2023)
Table 9. Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Tardive Dyskinesia Treatment Medicine Market Share by Region (2024-2033)
Table 11. Tardive Dyskinesia Treatment Medicine Market Trends
Table 12. Tardive Dyskinesia Treatment Medicine Market Drivers
Table 13. Tardive Dyskinesia Treatment Medicine Market Challenges
Table 14. Tardive Dyskinesia Treatment Medicine Market Restraints
Table 15. Global Tardive Dyskinesia Treatment Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Tardive Dyskinesia Treatment Medicine Market Share by Players (2018-2023)
Table 17. Global Top Tardive Dyskinesia Treatment Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia Treatment Medicine as of 2022)
Table 18. Ranking of Global Top Tardive Dyskinesia Treatment Medicine Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Tardive Dyskinesia Treatment Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Tardive Dyskinesia Treatment Medicine Product Solution and Service
Table 22. Date of Enter into Tardive Dyskinesia Treatment Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Type (2018-2023)
Table 26. Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Type (2024-2033)
Table 28. Global Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Application (2018-2023)
Table 30. Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Application (2024-2033)
Table 32. North America Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 47. Teva Pharmaceutical Company Detail
Table 48. Teva Pharmaceutical Business Overview
Table 49. Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Product
Table 50. Teva Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 51. Teva Pharmaceutical Recent Development
Table 52. Neurocrine Biosciences Company Detail
Table 53. Neurocrine Biosciences Business Overview
Table 54. Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Product
Table 55. Neurocrine Biosciences Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 56. Neurocrine Biosciences Recent Development
Table 57. Sun Pharmaceutical Company Detail
Table 58. Sun Pharmaceutical Business Overview
Table 59. Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Product
Table 60. Sun Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 61. Sun Pharmaceutical Recent Development
Table 62. SteriMax Company Detail
Table 63. SteriMax Business Overview
Table 64. SteriMax Tardive Dyskinesia Treatment Medicine Product
Table 65. SteriMax Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 66. SteriMax Recent Development
Table 67. Adamas Pharmaceuticals (Supernus) Company Detail
Table 68. Adamas Pharmaceuticals (Supernus) Business Overview
Table 69. Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Product
Table 70. Adamas Pharmaceuticals (Supernus) Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 71. Adamas Pharmaceuticals (Supernus) Recent Development
Table 72. AbbVie Company Detail
Table 73. AbbVie Business Overview
Table 74. AbbVie Tardive Dyskinesia Treatment Medicine Product
Table 75. AbbVie Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tardive Dyskinesia Treatment Medicine Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Tardive Dyskinesia Treatment Medicine Market Share by Type: 2022 VS 2033
Figure 3. Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors Features
Figure 4. Botulinum Toxin Features
Figure 5. Others Features
Figure 6. Global Tardive Dyskinesia Treatment Medicine Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Tardive Dyskinesia Treatment Medicine Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Tardive Dyskinesia Treatment Medicine Report Years Considered
Figure 12. Global Tardive Dyskinesia Treatment Medicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Tardive Dyskinesia Treatment Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Tardive Dyskinesia Treatment Medicine Market Share by Region: 2022 VS 2033
Figure 15. Global Tardive Dyskinesia Treatment Medicine Market Share by Players in 2022
Figure 16. Global Top Tardive Dyskinesia Treatment Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia Treatment Medicine as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Tardive Dyskinesia Treatment Medicine Revenue in 2022
Figure 18. North America Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Tardive Dyskinesia Treatment Medicine Market Share by Country (2018-2033)
Figure 20. United States Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Tardive Dyskinesia Treatment Medicine Market Share by Country (2018-2033)
Figure 24. Germany Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Tardive Dyskinesia Treatment Medicine Market Share by Region (2018-2033)
Figure 32. China Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Tardive Dyskinesia Treatment Medicine Market Share by Country (2018-2033)
Figure 40. Mexico Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Share by Country (2018-2033)
Figure 44. Turkey Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Teva Pharmaceutical Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 47. Neurocrine Biosciences Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 48. Sun Pharmaceutical Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 49. SteriMax Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 50. Adamas Pharmaceuticals (Supernus) Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 51. AbbVie Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed